Skip to content
Triangle logo TriangleGet started
← Acute Myeloid Leukemia

HEALTH PROFESSIONAL · SOURCE READING

Idarubicin and cytarabine

Source: Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 14, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Refractory or Recurrent AML / Chemotherapy / Intensive salvage chemotherapy

Evidence (idarubicin and cytarabine):

Reported results have been similar to those for the combination of cytarabine and mitoxantrone.[10,11]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice